We are live on
!
Find out more
DZ Bank Portfolio holdings
AUM
$113B
1-Year Est. Return
36.92%
This Fund
S&P 500
This Quarter
Est. Return
-1.28%
1 Year Est. Return
+36.92%
3 Year Est. Return
+150.91%
5 Year Est. Return
+223.96%
10 Year Est. Return
–
AUM
$70.4B
AUM Growth
+$3.85B
(+5.8%)
Cap. Flow
+$4.62B
Cap. Flow
% of AUM
6.56%
Top 10 Holdings %
Top 10 Hldgs %
34.8%
Holding
1,088
New
69
Increased
276
Reduced
305
Closed
107
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$1.1B |
| 2 |
UnitedHealth
UNH
|
+$936M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$755M |
| 4 |
Oracle
ORCL
|
+$638M |
| 5 |
Humana
HUM
|
+$605M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$566M |
| 2 |
Accenture
ACN
|
+$454M |
| 3 |
PPG Industries
PPG
|
+$430M |
| 4 |
Coca-Cola
KO
|
+$421M |
| 5 |
Advanced Micro Devices
AMD
|
+$413M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.89% |
| 2 | Healthcare | 16.66% |
| 3 | Financials | 10.28% |
| 4 | Consumer Discretionary | 8.89% |
| 5 | Industrials | 8.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Franco-Nevada
FNV
$41.3B
| $30.8M | 0.04% |
230,084
+108,028
| +89% | +$15.3M |
|
202
Equinix
EQIX
$99.4B
| $30.7M | 0.04% |
42,253
+7,917
| +23% | +$6.13M |
|
203
Molina Healthcare
MOH
$10.4B
| $30.7M | 0.04% |
93,582
-49,248
| -34% | -$15.5M |
|
204
Manhattan Associates
MANH
$11.9B
| $30.4M | 0.04% |
154,010
+129,859
| +538% | +$25.3M |
|
205
Elevance Health
ELV
$81.5B
| $29.9M | 0.04% |
68,589
+1,964
| +3% | +$891K |
|
|
K
206
DELISTED
Kellanova
K
| $29.6M | 0.04% |
529,299
+128,927
| +32% | +$7.67M |
|
207
Sempra
SRE
$58.1B
| $29.2M | 0.04% |
428,648
-290,566
| -40% | -$21M |
|
208
Kenvue
KVUE
$38B
| $28.2M | 0.04% |
+1,406,267
| New | +$32.6M |
|
209
Telus
TU
$17.4B
| $28.2M | 0.04% |
1,716,377
-1,494,913
| -47% | -$26.3M |
|
210
S&P Global
SPGI
$124B
| $28.1M | 0.04% |
76,935
+13,256
| +21% | +$5.21M |
|
211
HP
HPQ
$26B
| $27.9M | 0.04% |
1,085,194
+371,742
| +52% | +$11.4M |
|
212
Monster Beverage
MNST
$95.1B
| $27.8M | 0.04% |
525,000
-98,341
| -16% | -$5.59M |
|
213
iShares Core S&P 500 ETF
IVV
$858B
| $27.8M | 0.04% |
64,678
+1,126
| +2% | +$504K |
|
214
CALL
Stellantis
STLA
$17.4B
| $27M | 0.04% |
+1,400,000
| New | +$26.2M |
|
215
Chevron
CVX
$382B
| $26.5M | 0.04% |
157,217
+15,155
| +11% | +$2.45M |
|
216
Canadian National Railway
CNI
$78.5B
| $26.1M | 0.04% |
241,716
-536,908
| -69% | -$61.6M |
|
217
Gilead Sciences
GILD
$165B
| $26M | 0.04% |
346,462
-479,705
| -58% | -$36.9M |
|
218
Lowe's Companies
LOW
$121B
| $25.9M | 0.04% |
124,433
+18,800
| +18% | +$4.23M |
|
219
CALL
lululemon athletica
LULU
$13.5B
| $25.6M | 0.04% |
66,100
| – | – |
|
220
Lear
LEA
$7.39B
| $25.1M | 0.04% |
186,778
+13,000
| +7% | +$1.88M |
|
221
UGI
UGI
$7.87B
| $25M | 0.04% |
1,085,879
+302,682
| +39% | +$7.51M |
|
222
WEC Energy
WEC
$36.3B
| $24.4M | 0.03% |
303,415
-127,000
| -30% | -$11M |
|
223
DexCom
DXCM
$29B
| $24.3M | 0.03% |
260,831
-32,019
| -11% | -$3.61M |
|
224
Sensient Technologies
SXT
$5.22B
| $24M | 0.03% |
409,550
| – | – |
|
225
Pembina Pipeline
PBA
$29.3B
| $23.6M | 0.03% |
782,518
-1,642,125
| -68% | -$50.6M |
|
Similar funds
VAM
DZ Bank's Q3 2023 Portfolio in Review
As of Q3 2023, DZ Bank held 1,088 positions worth $70.4B, up 5.8% from $66.5B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
DZ Bank deployed $4.62B of net new capital in Q3 2023, opening 69 new positions and adding to 276 existing holdings. Its largest new stake was Kenvue: 1,406,267 shares worth $28.2M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Edwards Lifesciences, an estimated $566M trimmed.
- DZ Bank's largest Q3 2023 buy was Kenvue: 1,406,267 shares worth $28.2M.
- DZ Bank added most to CRH in Q3 2023, an estimated $1.1B increase.
- DZ Bank's biggest Q3 2023 reduction was Edwards Lifesciences, cutting an estimated $566M.
- DZ Bank fully exited Zimmer Biomet in Q3 2023, selling an estimated $52M.
- DZ Bank's ten largest holdings make up 35% of its $70.4B portfolio in Q3 2023.
- DZ Bank opened 69 new positions and closed 107 in Q3 2023.
- DZ Bank's portfolio value rose 5.8% quarter-over-quarter to $70.4B.
Based on DZ Bank's 13F filing for Q3 2023, filed 14 Nov 2023.